Im just frustrated because the thing that i was waiting for and the thing that could potentially get us up high again is the peopeietry version of omomyc. Why did they not even mention these supposedly parallel running trials?
Strategy perhaps? It’s well known that if a company wants to improve its chances of sustaining a share price rise, one good announcement must be followed up by another, in fairly close proximity.
The classic one-two punch.
First announcement confirms that a PYC proprietary peptide can effectively and safely deliver a Myc-inhibitor. Concept proven.
Second announcement (coming very soon) will hopefully confirm that a PYC proprietary peptide can perform as effectively, or more effectively than Omomyc, as a Myc-inhibitor.
PYC Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)